HOME >> BIOLOGY >> NEWS
Biomedical scientist testing nanoparticles as early cancer detection agent

various patients. Even when cells appear to be similar under the microscope, their genes and proteins may be decidedly different, which explains why cancer patients with apparently similar cancers sometimes respond differently to the same treatment.

Nie and his colleagues are working on methods to deliver nanoparticles into specific kinds of tissues and cells -- a process that would make cancer therapy more selective. Using near-infrared imaging technology, they are monitoring the migration of the particles within cells.

Nie is also working with tissue engineers at Georgia Tech and Emory to study the use of nanoparticles to construct new materials that could be used as improved implants for damaged tissue, such as bone, cartilage, or skin. Bio-nanomaterials provide new opportunities in cell and tissue engineering, such as cell growth/differentiation, tissue scaffolding, and controlled release of multiple growth factors.


'"/>

Contact: Larry Bowie
larry.bowie@icpa.gatech.edu
404-894-6016
Georgia Institute of Technology Research News
23-Oct-2002


Page: 1 2 3 4

Related biology news :

1. Pittsburgh NMR Center for Biomedical Research at Carnegie Mellon
2. Biomedical engineer constructs illuminating nanoparticles for medical imaging and gene detection
3. Yale researcher receives $1.3 million NIH grant to build Center of Excellence in Biomedical Computing
4. Rutgers to start up National Program of Excellence in Biomedical Computing
5. University of Pittsburgh, Carnegie Mellon University establish Biomedical Security Institute to address bioterrorism, public health threats
6. Biomedical scientists from Russia to Rio to explore biologys frontiers at HHMI in June
7. Biomedical switch regulates how cells stick together and communicates
8. Biomedical engineers working to help kids with special needs
9. Cutting The Time And Cost Of Developing New Cures: Lord Sainsbury Launches Worlds First Biomedical Accelerator Mass Spectrometer In York
10. Nations Leading Biomedical Researchers Present Breakthroughs in Liver Disease
11. University Of Kentucky Biomedical Engineer Awarded Grant To Improve Joint Replacements And Dental Implants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/4/2017)...  CES 2017 – Valencell , the leading ... the launch of two new versions of its ... sensor modules that incorporate the best of Valencell,s ... The two new designs include Benchmark BE2.0, a ... Benchmark BW2.0, a 2-LED version of its original ...
(Date:12/20/2016)... 20, 2016   Valencell , the leading ... STMicroelectronics (NYSE: STM), a global semiconductor leader ... announced today the launch of a new, highly ... that includes ST,s compact SensorTile turnkey ... biometric sensor system. Together, SensorTile and Benchmark deliver ...
(Date:12/15/2016)... and BADEN-BADEN, Germany , December ... leading global financial services provider, today announced an agreement with ... behavioural biometrics, to join forces. The partnership will enable clients ... strategies in compliance with local data protection regulation. ... In order to ...
Breaking Biology News(10 mins):
(Date:1/24/2017)... - BioAmber Inc. (NYSE: BIOA ) announced that, ... the size of the offering by 75% and purchase 3,684,212 ... to purchase 1,842,106 shares of common stock of the Company ... stock (the "Exercise Price"), at a price to the public ... The warrants have a term of four (4) years, exercisable ...
(Date:1/24/2017)... , ... January 24, 2017 , ... ... circumference, and increased serum leptin levels had a positive association with increased prostate ... study published in the International Neurourology Journal involved 571 Korean men who ...
(Date:1/24/2017)... Franklin, MA, USA & Geneva, Switerland (PRWEB) , ... ... ... are pleased to announce the first commercially available malaria Plasmodium falciparum culture panels ... Malaria P. falciparum culture panels, which are available in a range of concentrations ...
(Date:1/24/2017)... , Jan. 24, 2017 /PRNewswire/ - ProMetic Life Sciences ... announced today that its orally active lead drug candidate, ... designation by the UK Medicines and Healthcare Products Regulatory ... A PIM designation is an early ... for the Early Access to Medicines Scheme ("EAMS"), intended ...
Breaking Biology Technology:
Cached News: